Endometrial cancer stage II

2 trials 1 recruiting MedDRA PT
2 Registered trials
1 Recruiting
2 Unique sponsors
1 Unique IMPs
0 Commercial trials
Drug classes (ATC)
L Oncology (ATC L) 1
— ATC code not specified 1
Mechanism of action (INN-stem analysis)
Monoclonal antibody (immune) 1 substance
Phase III: 1 Phase II: 1

Filter these 2 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 2 trials

Phase III

1 trial
  • Universitair Medisch Centrum Utrecht Academic
    IMP not specified
    2024-516708-40-00 1 country 2024 n=10
    Ended

Phase II

1 trial
  • Grupo Espanol De Investigacion En Cancer De Ovario Academic
    DOSTARLIMAB
    2024-512021-81-00 1 country 2025 n=25
    Recruiting
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Grupo Espanol De Investigacion En Cancer De Ovario Academic 1 Phase II 1
Universitair Medisch Centrum Utrecht Academic 1 Phase III 0
New trials by year
2024
1
2025
1
← All indication landscapes